Jonah Goldberg: Trump's goal is to solidify control over the GOP, not help it win elections
The irony is that Trump is now grappling with the woes of being the establishment.
Source: postbulletin.com
📰 Jacques Mallet News
Page 3 - Jacques Mallet News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Jacques Mallet. Real-time updates on events, politics, business and more.
Goldberg:Trump's goal isn't to help win elections
Sen. Ted Cruz of Texas said something interesting while campaigning for Dave McCormick, one of the contenders for the GOP nomination to replace departing Sen. Pat Toomey of Pennsylvania.
Source: vaildaily.com
Jonah Goldberg: Trump's goal is to solidify control over the GOP, not help it win elections | Jonah Goldberg
Sen. Ted Cruz of Texas said something interesting while campaigning for Dave McCormick, one of the contenders for the GOP nomination to replace departing Sen. Pat Toomey of Pennsylvania.
Source: newsadvance.com
Jonah Goldberg: Trump's goal is to solidify control over the GOP, not help it win elections
Sen. Ted Cruz of Texas said something interesting while campaigning for Dave McCormick, still in the running for the GOP nomination to replace departing Sen. Pat Toomey of Pennsylvania. “Just once, I’d love to see a Republican candidate stand up in a primary and say: ‘I am a moderate, establishment
Source: triblive.com
Column: Want Trump's endorsement? Follow a few easy steps
GOP primaries are no longer about running on ideology or even competence. Those aren’t ways to differentiate among MAGA candidates.
Source: latimes.com
Onxeo Reports its Full-Year 2021 Financial Results and Announces Additional Financing of €12 Million
> Cash position of €17.9 million as of December 31, 2021 > Additional financing of €12 million subscribed by historical shareholders Invus and Financière de la Montagne in the form of the issuance
Source: finanznachrichten.de
Onxeo S.A.: Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare Sector
Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy at Sanofi, join the Company's Board as independent members Regulatory
Source: finanznachrichten.de
Onxeo Further strengthens its Board of Directors with two Seasoned Personalities from the Healthcare
Dr Robert L. Coleman, Chief Scientific Officer of US Oncology Network and Dr Jacques Mallet, former SVP Portfolio Analytics/Corporate Strategy at Sanofi, join the Company’s Board as independent membersPARIS--(BUSINESS WIRE)--Regulatory News:Onxeo S.A. (Euronext Growth Paris: ALONX, Nasdaq First North: ONXEO), « Onxe...
Source: pharmiweb.com